SCHEMBL10167880

SCHEMBL10167880

COCCOc1ccc2nc3ccc(=O)cc-3oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
APP P05067 13/20 1.00
CYP1A2 P05177 1/20 0.76
GRM4 Q14833 2/20 0.45
GPR119 Q8TDV5 1/20 0.41
TLR7 Q9NYK1 2/20 0.40
MIF P14174 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10167881 0.96 APP (1.00) APPCYP1A2GRM4TLR7MIF
SCHEMBL10167882 0.92 APP (1.00) APPCYP1A2TLR7
SCHEMBL16069679 0.89 APP (0.81) APPCYP1A2TLR7
SCHEMBL1104925 0.89 APP (0.80) APPCYP1A2TLR7
SCHEMBL10167883 0.89 APP (0.93) APPCYP1A2TLR7
SCHEMBL505449 0.87 APP (0.78) APPCYP1A2
SCHEMBL31492097 0.87 APP (0.78) APPCYP1A2
SCHEMBL10167874 0.86 APP (1.00) APPCYP1A2
SCHEMBL10167873 0.86 APP (1.00) APPCYP1A2TLR7
Ethoxyresorufin SCHEMBL104497 0.86 APP (1.00) APPCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9216974-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2015-12-22 US disclosed
US-9216974-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2015-12-22 US disclosed
US-9115099-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2015-08-25 US disclosed
US-9115099-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2015-08-25 US disclosed
US-20150175589-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF UNIV WASHINGTON (US) 2015-06-25 US disclosed
US-20150175589-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF UNIV WASHINGTON (US) 2015-06-25 US disclosed
US-20140221647-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2014-08-07 US disclosed
US-20140221647-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2014-08-07 US disclosed
US-8735575-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2014-05-27 US disclosed
US-8735575-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2014-05-27 US disclosed
US-20120035359-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF THE WASHINGTON UNIVERSITY (US) 2012-02-09 US disclosed
US-20120035359-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF THE WASHINGTON UNIVERSITY (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221647-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF PPOX, CYP4Z1, PRDX2 APP 3242/4885CYP1A2 12/4885GRM4 1878/4885
US-20150175589-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF PPOX, CYP4Z1, PRDX2 APP 3242/4885CYP1A2 12/4885GRM4 1878/4885
US-20120035359-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF PPOX, CYP4Z1, PRDX2 APP 3242/4885CYP1A2 12/4885GRM4 1878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.